Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonist.
第一作者:
An-Na,Moon
第一单位:
College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, South Korea; iLeadBMS Co., Ltd., 614 Dongtangiheung-ro, Hwaseong-si 18469, South Korea.
作者:
主题词
小鼠(Mice);动物(Animals);受体, 胞质和核(Receptors, Cytoplasmic and Nuclear);肝(Liver);肝硬化(Liver Cirrhosis);胆汁酸类和盐类(Bile Acids and Salts)
DOI
10.1016/j.biopha.2024.116331
PMID
38428307
发布时间
2024-03-27
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文